MDMA 2016 Annual Meeting
*Speakers will be added as confirmed
Click Here for a PDF of the Agenda
Wednesday, May 4, 2016
3:00pm - 5:00pm - Pre-Registration
Attendees are encouraged to come and pick up their meeting booklet, nametag and other information prior to the opening reception.
5:00pm - 6:30pm - Opening Reception
Enjoy networking with medical technology executives and other industry leaders while hearing from legendary entrepreneur and venture capitalist Mir Imran.
- Mir Imran, Chairman & CEO, InCube Labs
Thursday, May 5, 2016
8:00am - 9:00am - Networking Continental Breakfast
9:00am - 9:15am - Opening Address
MDMA's Chairman of the Board and MDMA's President and CEO will provide a review of Congressional activities and work with regulatory agencies to protect America's global leadership position in medical technology.
- Scott Huennekens, President & CEO, Verb Surgical, Inc., MDMA Chairman
- Mark Leahey, President & CEO, MDMA
9:15am - 10:15am -State of Innovation
leading innovator and policy
maker will layout the most pressing challenges facing the med tech
ecosystem, and share their thoughts and proposals how industry and other
stakeholders can accelerate patient-access and improve care in the 21st
- Dean Kamen, Founder, DEKA Research and Development Corporation
- Jeffrey Shuren, MD, Director, Center for Devices and Radiological Health, U.S. Food & Drug Administration
10:15am - 10:45am -CMS Update
As CMS continues to develop new reimbursement models and incentives for innovators, hear from the agency's Acting Administrator on how you and your teams can prepare for this new environment, and what other reforms CMS is working on.
- Andy Slavitt, Acting Administrator, Center for Medicare & Medicaid Services (CMS)
10:45am - 11:45am - Building the Right Culture & Team to Lead Your Organization
your teams take on more responsibilities and face novel challenges in
the business world - both in the United States and abroad - executives
will share their approaches to building value for their shareholders
while strengthening their teams and optimizing growth.
- Scott Huennekens, President & CEO, Verb Surgical, Inc., MDMA Chairman
- Benson Smith, Chairman, President & CEO, Teleflex Incorporated
11:45am - 12:00pm - Networking Break
12:00pm - 1:30pm - Luncheon - Advocacy & Engagement: Lessons Learned from Device Tax Suspension
While you enjoy lunch with colleagues, hear from CEOs about their efforts that helped secure suspension of the medical device tax, as well as how you can apply these lessons to whatever challenges and issues you and your team are facing in Washington.
- Joe Damico, Founding Partner & Co-Chairman, RoundTable Healthcare Partners
- Jeff McCaulley, President & CEO, Smiths Medical
- Rick Packer, Chairman, ZOLL Medical
1:30pm - 2:30pm - C-Suite Perspective - Adapting in Challenging Times: From Formation, Growth and Successful Exits
The myriad of challenges facing med tech leaders today can be daunting, from securing reimbursement and necessary funding, to managing growth and weighing options for potential exits. Hear from three executives who have led companies of all sizes through successful growth and what their advice is today to confront the daily obstacles and opportunities in the marketplace.
- Paul LaViolette, Managing Partner & COO, SV Life Sciences Advisors
- Eric Major, President, CEO & CoFounder, K2M, Inc.
- Daniel Moore, Chairman, LivaNova PLC
2:30pm - 3:00pm - Networking Break
3:00pm - 4:00pm - FDA's Broader Vision
The recently confirmed FDA Commissioner will discuss his vision for FDA and his 2016 priorities, many of which align with MDMA's own priorites. Dr. Califf will also discuss
opportunities where medical technology innovators can help shape the
ongoing reforms being implemented at FDA.
- Robert M. Califf, MD, Commissioner, U.S. Food & Drug Administration
4:00pm - 5:00pm - 2016 Election Preview
Control of Congress and the White House will be on the ballot in 2016, and some of the nation's leading strategists will share their insights on the state of the races, as well as what the various outcomes will mean for business and innovation. This bipartisan, interactive panel will answer attendees' questions and focus on the elections' impact on tax reform, trade issues, education, infrastructure and much more.
- Kevin Madden, Veteran Presidential Campaign Strategist
5:00pm - 6:30pm - MDMA Chairman's Reception
Enjoy networking with medical technology executives, policy makers and other industry leaders while honoring two public officials who are central figures in the fight to end the medical device tax, and helped lead the efforts to secure the two year suspension.
Friday, May 6, 2016
7:30am - 7:55am - Networking Continental Breakfast
8:00am - 8:30am - Changing Patent Landscape
The courts and Congress continue to explore changes to the nation's patent law. Experts will discuss the ongoing dynamics facing the patent system, and what companies should do to protect their IP.
- Kathleen Daley, Partner, Finnegan Henderson Farabow Garrett & Dunner LLP
- J. Michael Jakes, Partner, Finnegan Henderson Farabow Garrett & Dunner LLP
- Robert Shaffer, Partner, Finnegan Henderson Farabow Garrett & Dunner LLP
8:30am - 9:00am - CMS Coverage Update
While FDA reforms continue to improve the regulatory framework, more and more companies are facing serious challenges to secure adequate coverage for their technologies. One of CMS' leading policy makers will detail what the agency is doing to ensure timely access for patients and providers.
- Tamara Syrek Jensen, Director, JD, Coverage and Analysis Group, Centers for Medicare & Medicaid Services (CMS)
9:00am - 10:15am - Adapting to the New Health Care Landscape
Panelists will discuss the current environment related to securing coverage and market access. In today's environment, various stake holders in the health care delivery system often have different definitions of value. Hear from leading experts and innovators on the steps companies should take to help ensure their technologies get into the hands of patients and providers.
- Louis Jacques, Senior Vice President & Chief Clinical Officer, ADVI
- Beth Roberts, Partner, Hogan Lovells (moderator)
- Thomas C. Royer, MD, FACPE, CEO Emeritus, CHRISTUS Health and CEO & Partner, Royer-Maddox-Herron Advisors
- Nadim Yared, President & CEO, CVRx, Inc.
10:15am - 10:45am - Networking Break
10:45am - 11:45am - Compliance Panel
With increasing attention focused on post-market issues and regulators shifting resources and investigations to health care fraud, learn the latest "best practices" that every team should know as you grow in the global market place.
- Carolyn Bruguera, Vice President & General Counsel, MDMA
- Adam Jones, General Counsel, Smiths Medical
- John Manthei, Partner, Latham & Watkins
- Michael Pauze', Partner, King & Spalding
- Benjamin Wallfisch, Senior Associate, Norton, Rose, Fulbright
11:45am - 12:30pm - International Panel: EU Directive Update and Changing Reimbursement Systems
Companies need to know the final details of the new EU Directive as well as the latest on the changing reimbursement systems and opportunities in the UK, Germany, France and Japan. Hear from some of the industry's top experts about how you should prepare to gain access to key overseas markets.
- Paul Bristow, Managing Director, PB Consulting
- Stephen Hull, Principal & Founder, Hull Associates
- Ed Rozynski, Chair, MDMA International Committee (moderator)
*Due to the election year Congressional schedule, both the House and Senate will be in recess during MDMA's Annual Meeting, which means Members of Congress will not be in Washington, D.C. As a result, we will not be hosting a Congressional fly-in this year. However, If you would still like to meet with staff members for your Members of Congress, MDMA would be glad to assist you. Interested registrants should contact Elliott Warren at email@example.com by COB, Friday, April 22nd to schedule a meeting with your Congressional delegation staff.
Sessions and speakers are subject to change without notice. MDMA reserves the right to cancel or reschedule any program, whereupon full registration fees will be refunded or applied to the rescheduled program in accordance with the registrant's preference. In the event of canceled programs, MDMA assumes no responsibility for transportation, hotel, or other expenses incurred by registrants.